Trial intelligence / Profile preview

Pregabalin or Baclofen for Spastic Motor Behaviour After Spinal Cord Injury

2024-518824-56-00Phase 3Authorised

Sponsor
Motol University Hospital
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Muscle spasm comparing Pregabalin arm with Baclofen arm (2 arms). Primary endpoint: Average MES score over 30 days. Planned start May 2026; status: authorised.

02

Drugs

pregabalinbaclofen
03

Conditions

Muscle spasm

Beyond the preview

Go deeper on 2024-518824-56-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518824-56-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call